Also found in: Dictionary, Medical, Wikipedia.
Related to Celebrex: Tramadol
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for Celebrex

a Cox-2 inhibitor (trade name Celebrex) that relieves pain and inflammation without harming the digestive tract

References in periodicals archive ?
Celebrex is signified for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis in addition to for the management of acute pain in adults.
increased gastrointestinal (GI) risk taking CELEBREX demonstrated a
In laboratory studies, University of Michigan researchers found that several coxibs, the drug class to which Celebrex belongs, interfere with aspirin's ability to discourage blood clots, if the aspirin is taken in low doses.
Pfizer Inc announced today that 17 European countries agreed to extend the Celebrex (celecoxib capsules) label to include symptomatic relief in the treatment of ankylosing spondylitis (in adults), a form of arthritis that affects the spine.
To carry out GAIT, 16 rheumatology research centers across the United States assigned more than 1,500 women and men with osteoarthritis of the knees to take a daily dose of glucosamine (1,500 mg), chondroitin (1,200 mg), both, Celebrex (200 mg), or a placebo.
Bextra is a Cox-2 nonsteroidal anti-inflammatory drug (NSAID) like Vioxx and Celebrex.
Additionally, in another cancer study involving the long-term use of Celebrex, there was no increased risk in patients taking a 400-mg daily dose.
saying the company misrepresented facts about the safety of two drugs, Celebrex and Bextra.
Just last week, Pfizer announced that a US study had found that its drug Celebrex, taken by an estimated 600,000 patients in the UK, increased the risk of heart problems and stroke.
Pfizer in the US said a study had found an increased risk of heart problems in patients taking its painkiller Celebrex - one of a class of drugs known as COX-2 inhibitors.
Celebrex, another COX-2 inhibitor, is marketed by Pfizer.
Step therapy would require a patient to try Motrin as a treatment option and cover Celebrex only if the Motrin is not an effective treatment measure.
Last year Pharmacia completed a US$15 million investment to expand production of Celebrex.